Michael W. Fanger, Ph.D.

As cofounder and CSO, Mike sets Celdara Medical’s scientific strategy, and provides leadership to individual Programs and mentorship throughout the organization. Formerly, Mike was the President and Chief Executive Officer of Celldex Therapeutics Inc. (NASDAQ: CLDX), as well as the Founder and Director of Medarex (formerly NASDAQ: MEDX; acquired by BMS in 2009 for $2.4B) from its inception in 1987 until 2004. Mike has been a Professor of Microbiology and Immunology and of Medicine at Dartmouth Medical School since 1981, and was Chairman of the Department of Microbiology and Immunology from 1992 until 2002. He is a graduate of Wabash College and received his Ph.D. in Biochemistry from Yale University.